Cargando…

Disequilibrium between BRCA1 and BRCA2 Circular and Messenger RNAs Plays a Role in Breast Cancer

SIMPLE SUMMARY: Breast cancer is a common disease that is responsible for the deaths of approximately 700,000 women per year i.e., 15.5% of all female deaths from cancer. Significant progress has been made in the management of breast cancer but new biomarkers for early detection and prognosis have y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levacher, Corentin, Viennot, Mathieu, Drouet, Aurélie, Beaussire, Ludivine, Coutant, Sophie, Théry, Jean-Christophe, Baert-Desurmont, Stéphanie, Laé, Marick, Ruminy, Philippe, Houdayer, Claude
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093293/ https://www.ncbi.nlm.nih.gov/pubmed/37046838 http://dx.doi.org/10.3390/cancers15072176

Ejemplares similares

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices
por: Toland, Amanda Ewart, et al.
Publicado: (2018)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
por: Hart, Steven N., et al.
Publicado: (2020)

Antagonism between BRCA2 and FIGL1 regulates homologous recombination
por: Kumar, Rajeev, et al.
Publicado: (2019)

Correction: Exonic Splicing Mutations Are More Prevalent than Currently Estimated and Can Be Predicted by Using In Silico Tools
por: Soukarieh, Omar, et al.
Publicado: (2016)

Exonic Splicing Mutations Are More Prevalent than Currently Estimated and Can Be Predicted by Using In Silico Tools
por: Soukarieh, Omar, et al.
Publicado: (2016)

Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay
por: Baert, Annelot, et al.
Publicado: (2017)

Epistatic Relationships in the BRCA1-BRCA2 Pathway
por: Scully, Ralph
Publicado: (2011)

A model of the BRCA1/BRCA2 network
por: Pujana, MA, et al.
Publicado: (2005)

Molecular Trajectory of BRCA1 and BRCA2 Mutations
por: Hatano, Yuichiro, et al.
Publicado: (2020)

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
por: Talhouet, Solene De, et al.
Publicado: (2020)

A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA
por: Esposito, Maria Valeria, et al.
Publicado: (2016)

BRCA1 and BRCA2 mutations in Scotland and Northern Ireland
Publicado: (2003)

Clinical significance of large rearrangements in BRCA1 and BRCA2
por: Judkins, Thaddeus, et al.
Publicado: (2012)

Autoimmune response to PARP and BRCA1/BRCA2 in cancer
por: Zhu, Qing, et al.
Publicado: (2015)

The germline mutational landscape of BRCA1 and BRCA2 in Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2018)

BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis
por: Li, Qianyan, et al.
Publicado: (2021)

Prediction of carrying a BRCA1 or BRCA2 mutation
por: Lee, Kyung-Hun
Publicado: (2023)

Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study
por: Denis-Laroque, Laurie, et al.
Publicado: (2021)

An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)
por: Chenevix-Trench, Georgia, et al.
Publicado: (2007)

Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
por: Pujol, Pascal, et al.
Publicado: (2022)

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes
por: De Talhouet, Solene, et al.
Publicado: (2020)

BRCA1, BRCA2 and their possible function in DNA damage response
por: Kote-Jarai, Z, et al.
Publicado: (1999)

Cancer risks among BRCA1 and BRCA2 mutation carriers
por: Levy-Lahad, E, et al.
Publicado: (2007)

BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
por: Purnomosari, Dewajani, et al.
Publicado: (2007)

Genetic testing for BRCA1 and BRCA2 mutations - ready for implementation?
por: Weber, BL
Publicado: (2000)

Genomic rearrangements in BRCA1 and BRCA2: A literature review
por: Ewald, Ingrid Petroni, et al.
Publicado: (2009)

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
por: McKinley, Joanne M, et al.
Publicado: (2007)

BRCA1 and BRCA2 mutations in central and southern Italian patients
por: Ottini, Laura, et al.
Publicado: (2000)

Rapid evolution of BRCA1 and BRCA2 in humans and other primates
por: Lou, Dianne I, et al.
Publicado: (2014)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)

Genetic Variation of the Brca1 and Brca2 Genes in Macedonian Patients
por: Maleva, I, et al.
Publicado: (2012)

Effect of the novel Moroccan BRCA1 and BRCA2 frameshift mutations
por: Tazzite, Amal, et al.
Publicado: (2013)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018)

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients
por: Manchana, Tarinee, et al.
Publicado: (2020)

Systematic misclassification of missense variants in BRCA1 and BRCA2 “coldspots”
por: Dines, Jennifer N., et al.
Publicado: (2020)

Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
por: Bajrami, Ilirjana, et al.
Publicado: (2021)

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
por: Li, Shuai, et al.
Publicado: (2022)

The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status
por: C.E, Drechsel Katja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9pdlmqaecreuvq0gdhk4r5d7m9